期刊文献+

Incidence and mortality of liver cancer in Henan province in 2015

原文传递
导出
摘要 Objective:Liver cancer is one of the most common types of cancer.We aimed to use the cancer registration data in 2015 to estimate the incidence and mortality of liver cancer in Henan province.Methods:The data from 37 population-based cancer registries in Henan province were collected for this study.The pooled data were stratified by area,sex,and age group.New cases of liver cancer and deaths due to the disease were estimated using age-specific rates and provincial population in 2015.All incidence and death rates were age standardized to the 2000 Chinese standard population and Segi's population,which were expressed per 100,000 populations.Results:After clearance and assessment,data from 30 population-based cancer registries(5 in urban and 25 in rural areas)were included in the analysis.All 30 cancer registries encompassed a total population of 23,421,609(3,507,984 in urban and 19,913,625 in rural areas),accounting for 21.84% of the provincial population.The proportion of morphological verification(MV%),percentage of cancer cases identified with death certification only(DCO%),and mortality-to-incidence ratio(M/I)were 38.55%,2.34%,and 0.81,respectively.Approximately 31,639 new cases of liver cancer were diagnosed and 26,057 deaths from liver cancer occurred in Henan in 2015.The crude incidence rate of liver cancer was 27.05/100,000(36.24/100,000 in men and 17.35/100,000 in women).Age-standardized incidence rates by Chinese standard population and world standard population were 21.10/100,000 and 20.95/100,000,respectively.Liver cancer was more common in men than in women.The incidence rates in urban(26.31/100,000)and rural(27.18/100,000)areas were similar.The crude mortality rate of liver cancer was 21.98/100,000(29.33/100,000 in males and 14.22/100,000 in females).Age-standardized mortality rates by Chinese standard population and world standard population were 16.93/100,000 and 16.90/100,000,respectively.There was no distinct difference in mortality rates of liver cancer between urban(22.55/100,000)and rural(21.87/100,000)areas.Conclusions: Liver cancer has posed a heavy burden on people in Henan province. Comprehensive measures should be conductedto prevent the increase in the incidence of liver cancer.
出处 《Chronic Diseases and Translational Medicine》 CSCD 2019年第3期197-202,共6页 慢性疾病与转化医学(英文版)
  • 相关文献

参考文献5

二级参考文献21

  • 1Chunfeng Qu,Zhongping Duan,Kun Chen,Huaibin Zou.Reducing liver cancer risk beginning at birth:experiences of preventing chronic hepatitis B virus infection in China[J].Hepatoma Research,2017,3(10):228-240. 被引量:7
  • 2Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015, 65(2):87-108.
  • 3International Agency for Reseawh on Cancer. GLOBOCAN 2012: estimated t'ancer incidence, mortality and prevalence worldwide in 2012,2014[ EB/OL]. [ 2014-12-16]. http://globocan.iarc.fr.
  • 4.l'eii,'()M i'rkif-DM, Macle,,na,, R, et al. Cancer registration principles and methods IARC Sci Pub No.95 [ M ]. Lyon: IARC, 1991:101-107.
  • 5Parkin DM, Chert VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19 [ J ]. l.yon: IARC, 1994:35-49.
  • 6Parkin DM, Bray F. Evaluation of data quality in the cancer registry. : principles and methxls Part I1. Completeness[ J ]. Eur J Cancer, 2009, 45 ( 5 ) : 756-764.
  • 7Bray F, Pu'kin DM. Evaluation of data quality in the cmlcer registry : principles and methods. Part 1: comparability, validity and limeliness[ J ]. Eur J Cancer, 2(108, 45(5) :747-755.
  • 8Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003- 2005: a population-based study [J]. lnt J Cancer. 2015. 136 (8) : 1921-1930.
  • 9Kim H J, Fay MP, Feuer EJ, el al. Permutation tests for joinpoint regression with applications to cancer rates [ J ]. Stat Med, 2000, 19(3) :335-351.
  • 10张思维,陈万青,雷正龙,邹小农,赵平.中国肿瘤登记处2004年恶性肿瘤发病资料分析[J].中国肿瘤,2008,17(11):909-912. 被引量:77

共引文献1075

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部